InnovAtlasMalaria No More
Technology and manufacturing company

CytoAstra LLC

Develop

CytoAstra develops Cytophone, a non-invasive malaria diagnostic device that uses laser light and sound signals to detect malaria-infected red blood cells through the skin without drawing blood.

2
Endemic countries
1
U.S. states
5
Products and programs
About

What they do

CytoAstra develops Cytophone, a non-invasive malaria diagnostic device that uses laser light and sound signals to detect malaria-infected red blood cells through the skin without drawing blood.1,2 Between 2020 and 2025, Cytophone underwent clinical evaluations in Cameroon, the United States, and Burkina Faso.2 The company is now preparing for commercialization and regulatory review.2 Its U.S. R&D and commercialization activities are based in Little Rock, Arkansas, and its malaria work is in the development stage.2

In the United States
Products and programs

In the field and in development

Cytophone1,2

Non-invasive photoacoustic malaria diagnostic device

Rapid, ultrasensitive malaria detection without a blood draw1,2
Research toward wearable devices for continuous, real-time monitoring of disease status2
Research on laser-based destruction of malaria parasites in infected red blood cells through intact skin2
Research on evaluating antimalarial drug and vaccine effectiveness using Cytophone2
Where they work

Partnerships in 2 endemic countries

Product testing
  • Institut des Sciences et Techniques, Bobo-Dioulasso · clinical evaluation of Cytophone in 2025, including adults and children2
Cameroon
Africa
  • University of Yaoundé I and Epicentre (Médecins Sans Frontières/Doctors Without Borders) · clinical evaluations of Cytophone in 2020 and 20243,4,2
U.S. partners

Who they work with in the United States

Sources

Where this comes from

  1. 1cytoastra.com
  2. 2Confirmed by the organization
  3. 3nature.com
  4. 4scienceportal.msf.org